Abstract
In this trial, nasopharyngeal cancer stem cells (CSCs) were separated and cultured to produce a vaccine; its safety and efficacy were prospectively evaluated in low-, medium-, and high-dose groups. Between April and September 2014, we enrolled 90 patients who met the enrolment criteria, and assigned them to three groups (n=30). Throughout the trial, injection site reaction was the most common reaction (81%), and fever was least common (31%); however, there was no difference among the three groups. When the immune responses pre- and post-vaccination were compared, we found that the CSC-specific and -nonspecific response in the medium- and high-dose groups were both significantly enhanced. This study is the first clinical trial of a nasopharyngeal CSC vaccine and preliminarily proves its safety and efficacy.
References
Jun 11, 2005·Journal of Vascular and Interventional Radiology : JVIR·S Nahum GoldbergUNKNOWN Society of Interventional Radiology Technology Assessment Committee
Dec 10, 2008·Blood·John E Dick
Apr 9, 2009·Pathology International·Noriyuki SatoToshihiko Torigoe
Jun 19, 2009·Stem Cells·Qijin XuJohn S Yu
Jul 3, 2009·Cell Stem Cell·Liqing JinRichard B Lock
Jul 28, 2009·Cell·Ravindra MajetiIrving L Weissman
Oct 3, 2009·Annals of the New York Academy of Sciences·Tobias Schatton, Markus H Frank
Feb 4, 2010·Anti-cancer Drugs·Francesco CaponigroFrancesco Perri
Feb 22, 2011·International Journal of Hematology·Anna MerloAntonio Rosato
May 27, 2011·International Journal of Biological Sciences·Jiang LiYi-xin Zeng
Jun 23, 2011·Expert Review of Vaccines·Janet Plate
Jan 25, 2012·Journal of Surgical Oncology·Ying JinWen-Qi Jiang
Apr 5, 2012·Cancer Research·Ning NingQiao Li
Jan 22, 2013·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Apr 26, 2013·The Laryngoscope·Fenggang YuKwok Seng Loh
Apr 27, 2013·Cryobiology·Lizhi NiuKecheng Xu
Apr 30, 2013·Journal of Vascular and Interventional Radiology : JVIR·Xin LiHao Zhang
Nov 23, 2013·Cancer Letters·Chang-Fu YangBi-Jun Huang
Dec 20, 2013·Clinical and Vaccine Immunology : CVI·Viviana P LutzkyDenis J Moss
Mar 29, 2014·Radiation Oncology·Jia-Xin LiTai-xiang Lu
Jun 14, 2014·Oncology Reports·Xin-Hua XuWei-Hong Chen
Aug 27, 2014·Stem Cell Research & Therapy·Pingpin WeiGuiyuan Li